Surging prevalence of infectious diseases, escalating threat of bioterrorism, rising resistance to anti-infective therapies propelling the demand for anti-infective vaccines
Date: 27 February 2017
According to Azoth Analytics research report, “GlobalAnti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral),By Region, By Country: Opportunities and Forecasts (2016-2021)
- By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China), Global Anti-Infective Vaccines Market is projected to exhibit a CAGR of over ~ 5.88% during 2016 – 2021, driven by the rising old age population in developing and developed regions, surge in healthcare infrastructure in developing regions, growing concerns over anti- viral & anti-bacterial diseases and development of bioterrorism have been driving the market for anti-infectious vaccines.
The market is segmented on the basis of two types of anti- infectious vaccines i.e. anti-viral and anti- bacterial. Among the segments, anti- bacterial is expected to witness tremendous growth owing to the rise in precaution medication among young and middle aged population with desire towards better and health life. Top global manufacturers have been focusing towards meeting the needs of the patients by developing various vaccines with multi cure and specific diseases
Among the regions, North America holds the major market due to a robust healthcare infrastructure combined with the high presence of drug manufacturers within the region. However, due to the growing middle class population as well as disposable income, market for APAC is expected to witness highest growth in the forecast period.